CymaBay Therapeutics, Inc.
CBAYDelisted Mar 22, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001042074
CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding CymaBay Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 113 | 1 | 114 | +2 |
| Shares | 52.2M | 91.4K | 46.4M | −5.69M (−10.9%) |
| Value | $227.4M | $399.0K | $169.3M | −$57.7M (−25.4%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Opaleye Management Inc. | 115,015 | $420.0K | 0.08% |
| HRT Financial LP | 51,853 | $189.0K | 0.00% |
| SG Americas Securities, LLC | 46,078 | $168.0K | 0.00% |
| Golden State Equity Partners | 32,850 | $120.0K | 0.05% |
| Myriad Asset Management Ltd. | 30,000 | $110.0K | 0.01% |
| Rafferty Asset Management, LLC | 26,748 | $98.0K | 0.00% |
| MetLife Investment Management | 26,489 | $96.7K | 0.00% |
| Algert Global LLC | 21,684 | $79.0K | 0.01% |
| Metropolitan Life Insurance Co | 20,041 | $73.2K | 0.00% |
| Bank of Montreal | 16,906 | $65.0K | 0.00% |
| Winton Group Ltd | 17,659 | $64.0K | 0.00% |
| Lake Street Financial LLC | 12,900 | $47.0K | 0.01% |
| AQR Capital Management LLC | 10,578 | $39.0K | 0.00% |
| LCM Capital Management Inc | 10,000 | $37.0K | 0.03% |
| Advisor Group Holdings, Inc. | 6,250 | $23.0K | 0.00% |
| Quantbot Technologies LP | 1,929 | $7.00K | 0.00% |
| Meridian Wealth Partners, LLC | 257 | $1.00K | 0.00% |
| Ellevest, Inc. | 39 | $0 | 0.00% |
| Gerber Kawasaki Wealth & Investment Management | 2 | $0 | 0.00% |
Sold out (17)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Boxer Capital, LLC | 4,000,000 | $17.4M |
| Norges Bank | 463,124 | $2.02M |
| Two Sigma Investments, LP | 271,216 | $1.18M |
| Commonwealth Equity Services, LLC | 113,394 | $494.0K |
| Tekla Capital Management LLC | 88,102 | $384.0K |
| Susquehanna International Group, LLP | 76,433 | $333.0K |
| Baker Avenue Asset Management, LP | 52,800 | $230.0K |
| XTX Topco Ltd | 33,658 | $147.0K |
| Windsor Creek Advisors, LLC | 29,770 | $130.0K |
| ExodusPoint Capital Management, LP | 28,719 | $125.0K |
| Jane Street Group, LLC | 15,085 | $66.0K |
| Schonfeld Strategic Advisors LLC | 15,003 | $65.0K |
| Group One Trading, L.P. | 11,540 | $50.0K |
| Engineers Gate Manager LP | 10,989 | $48.0K |
| Hartford Financial Management Inc. | 800 | $3.00K |
| Hantz Financial Services, Inc. | 75 | $0 |
| Quadrant Capital Group LLC | 107 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 91,400 | $399.0K |